These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028 [TBL] [Abstract][Full Text] [Related]
25. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives. Norrish G; Jager J; Field E; Quinn E; Fell H; Lord E; Cicerchia MN; Ochoa JP; Cervi E; Elliott PM; Kaski JP Circulation; 2019 Jul; 140(3):184-192. PubMed ID: 31006259 [TBL] [Abstract][Full Text] [Related]
26. Evolution of genetic testing and gene therapy in hypertrophic cardiomyopathy. Chiswell K; Zaininger L; Semsarian C Prog Cardiovasc Dis; 2023; 80():38-45. PubMed ID: 37137376 [TBL] [Abstract][Full Text] [Related]
27. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy. Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006 [TBL] [Abstract][Full Text] [Related]
28. Molecular Genetic Basis of Hypertrophic Cardiomyopathy. Marian AJ Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830 [TBL] [Abstract][Full Text] [Related]
29. Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy. Captur G; Lopes LR; Mohun TJ; Patel V; Li C; Bassett P; Finocchiaro G; Ferreira VM; Esteban MT; Muthurangu V; Sherrid MV; Day SM; Canter CE; McKenna WJ; Seidman CE; Bluemke DA; Elliott PM; Ho CY; Moon JC Circ Cardiovasc Imaging; 2014 Nov; 7(6):863-71. PubMed ID: 25228707 [TBL] [Abstract][Full Text] [Related]
30. Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY). Mirabel M; Damy T; Donal E; Huttin O; Labombarda F; Eicher JC; Cervino C; Laurito M; Offredo L; Tafflet M; Jouven X; Giura G; Desnos M; Jeunemaître X; Empana JP; Charron P; Habib G; Réant P; Hagège A; Int J Cardiol; 2019 Jan; 275():107-113. PubMed ID: 30316646 [TBL] [Abstract][Full Text] [Related]
31. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. Maron BJ; Maron MS; Semsarian C J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258 [TBL] [Abstract][Full Text] [Related]
32. Genetic screening of patients with hypertrophic cardiomyopathy--a new diagnostic strategy for risk stratification? Hudecova K; Simkova I; Gardlik R; Bernadic M Bratisl Lek Listy; 2009; 110(2):85-92. PubMed ID: 19408839 [TBL] [Abstract][Full Text] [Related]
33. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting. Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739 [TBL] [Abstract][Full Text] [Related]
34. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study. Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ; JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245 [TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals. Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316 [TBL] [Abstract][Full Text] [Related]
36. Genetic Testing for Diagnosis of Hypertrophic Cardiomyopathy Mimics: Yield and Clinical Significance. Hoss S; Habib M; Silver J; Care M; Chan RH; Hanneman K; Morel CF; Iwanochko RM; Gollob MH; Rakowski H; Adler A Circ Genom Precis Med; 2020 Apr; 13(2):e002748. PubMed ID: 32150461 [TBL] [Abstract][Full Text] [Related]
37. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy. Joy G; Kelly CI; Webber M; Pierce I; Teh I; McGrath L; Velazquez P; Hughes RK; Kotwal H; Das A; Chan F; Bakalakos A; Lorenzini M; Savvatis K; Mohiddin SA; Macfarlane PW; Orini M; Manisty C; Kellman P; Davies RH; Lambiase PD; Nguyen C; Schneider JE; Tome M; Captur G; Dall'Armellina E; Moon JC; Lopes LR Circulation; 2023 Sep; 148(10):808-818. PubMed ID: 37463608 [TBL] [Abstract][Full Text] [Related]
38. Clinical application of WHF-MOGE(S) classification for hypertrophic cardiomyopathy. Agarwal A; Yousefzai R; Jan MF; Cho C; Shetabi K; Bush M; Khandheria BK; Paterick TE; Treiber S; Sra J; Werner P; Allaqaband S; Bajwa T; Tajik AJ Glob Heart; 2015 Sep; 10(3):209-19. PubMed ID: 26271555 [TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy. Bottillo I; D'Angelantonio D; Caputo V; Paiardini A; Lipari M; De Bernardo C; Giannarelli D; Pizzuti A; Majore S; Castori M; Zachara E; Re F; Grammatico P Gene; 2016 Feb; 577(2):227-35. PubMed ID: 26656175 [TBL] [Abstract][Full Text] [Related]
40. Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy. Lakdawala NK; Olivotto I; Day SM; Han L; Ashley EA; Michels M; Ingles J; Semsarian C; Jacoby D; Jefferies JL; Colan SD; Pereira AC; Rossano JW; Wittekind S; Ware JS; Saberi S; Helms AS; Cirino AL; Leinwand LA; Seidman CE; Ho CY Circ Genom Precis Med; 2021 Feb; 14(1):e003062. PubMed ID: 33284039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]